Novel insights in the relationship of gut microbiota and coronary artery diseases

References

• Aboyans, V., J. B. Ricco, M. E. L. Bartelink, M. Björck, M. Brodmann, T. Cohnert, J. P. Collet, M. Czerny, M. De Carlo, S. Debus, et al. 2018. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European Heart Journal 39 (9):763–816. doi: 10.1093/eurheartj/ehx095.
   PubMed Web of Science ®Google Scholar
• Ahmad, A. F., L. Rich, H. Koch, K. D. Croft, M. G. Ferruzzi, C. D. Kay, J. M. Hodgson, and N. C. Ward. 2018. Effect of adding milk to black tea on vascular function in healthy men and women: A randomised controlled crossover. Food & Function 9 (12):6307–14. doi: 10.1039/C8FO01019F.
   PubMed Web of Science ®Google Scholar
• Altmann, S. W., H. R. Davis Jr., L. J. Zhu, X. Yao, L. M. Hoos, G. Tetzloff, S. P. Iyer, M. Maguire, A. Golovko, M. Zeng, et al. 2004. Niemann-pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science (New York, N.Y.) 303 (5661):1201–4. doi: 10.1126/science.1093131.
   PubMed Web of Science ®Google Scholar
• Ambrose, J. A., and M. Singh. 2015. Pathophysiology of coronary artery disease leading to acute coronary syndromes. F1000prime Reports 7:8. doi: 10.12703/P7-08.
   PubMedGoogle Scholar
• Aron-Wisnewsky, J., and K. Clement. 2016. The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nature Reviews. Nephrology 12 (3):169–81. doi: 10.1038/nrneph.2015.191.
   PubMed Web of Science ®Google Scholar
• Aronson, D., and E. R. Edelman. 2016. Coronary artery disease and diabetes mellitus. Heart Failure Clinics 12 (1):117–33. doi: 10.1016/j.hfc.2015.08.010.
   PubMed Web of Science ®Google Scholar
• Barko, P. C., M. A. McMichael, K. S. Swanson, and D. A. Williams. 2018. The gastrointestinal microbiome: A review. Journal of Veterinary Internal Medicine 32 (1):9–25. doi: 10.1111/jvim.14875.
   PubMed Web of Science ®Google Scholar
• Barrea, L., G. Annunziata, G. Muscogiuri, D. Laudisio, C. D. Somma, M. Maisto, G. C. Tenore, A. Colao, and S. Savastano. 2019. Trimethylamine N-oxide, Mediterranean diet, and nutrition in healthy, normal-weight adults: Also a matter of sex? Nutrition 62:7–17. doi: 10.1016/j.nut.2018.11.015.
   PubMed Web of Science ®Google Scholar
• Battson, M. L., D. M. Lee, D. K. Jarrell, S. Hou, K. E. Ecton, T. L. Weir, and C. L. Gentile. 2018. Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction. American Journal of Physiology-Endocrinology and Metabolism 314 (5):E468–77. doi: 10.1152/ajpendo.00187.2017.
   PubMed Web of Science ®Google Scholar
• Bogiatzi, C., G. Gloor, E. Allen-Vercoe, G. Reid, R. G. Wong, B. L. Urquhart, V. Dinculescu, K. N. Ruetz, T. J. Velenosi, M. Pignanelli, et al. 2018. Metabolic products of the intestinal microbiome and extremes of atherosclerosis. Atherosclerosis 273:91–7. doi: 10.1016/j.atherosclerosis.2018.04.015.
   PubMed Web of Science ®Google Scholar
• Caparrós-Martín, J. A., R. R. Lareu, J. P. Ramsay, J. Peplies, F. J. Reen, H. A. Headlam, N. C. Ward, K. D. Croft, P. Newsholme, J. D. Hughes, et al. 2017. Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism. Microbiome 5 (1):95. doi: 10.1186/s40168-017-0312-4.
   PubMedGoogle Scholar
• Carding, S., K. Verbeke, D. T. Vipond, B. M. Corfe, and L. J. Owen. 2015. Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health and Disease 26:26191. doi: 10.3402/mehd.v26.26191.
   PubMed Web of Science ®Google Scholar
• Catry, E., B. D. Pachikian, N. Salazar, A. M. Neyrinck, P. D. Cani, and N. M. Delzenne. 2015. Ezetimibe and Simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism. Life Sciences 132:77–84. doi: 10.1016/j.lfs.2015.04.004.
   PubMed Web of Science ®Google Scholar
• Causey, J. L., J. M. Feirtag, D. D. Gallaher, B. C. Tungland, and J. L. Slavin. 2000. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal, environment in hypercholesterolemic men. Nutrition Research 20 (2):191–201. doi: 10.1016/S0271-5317(99)00152-9.
   Web of Science ®Google Scholar
• Cosola, C., M. De Angelis, M. T. Rocchetti, E. Montemurno, V. Maranzano, G. Dalfino, C. Manno, A. Zito, M. Gesualdo, M. M. Ciccone, et al. 2017. Beta-glucans supplementation associates with reduction in P-cresyl sulfate levels and improved endothelial vascular reactivity in healthy individuals. PLoS One 12 (1):e0169635. doi: 10.1371/journal.pone.0169635.
   PubMed Web of Science ®Google Scholar
• Coughlin, S. R. 2000. Thrombin signalling and protease-activated receptors. Nature 407 (6801):258–64. doi: 10.1038/35025229.
   PubMed Web of Science ®Google Scholar
• Cui, L., T. Zhao, H. Hu, W. Zhang, and X. Hua. 2017. Association study of gut flora in coronary heart disease through high-throughput sequencing. BioMed Research International 2017:1–10. doi: 10.1155/2017/3796359.
   Web of Science ®Google Scholar
• DeGruttola, A. K., D. Low, A. Mizoguchi, and E. Mizoguchi. 2016. Current understanding of dysbiosis in disease in human and animal models. Inflammatory Bowel Diseases 22 (5):1137–50. doi: 10.1097/MIB.0000000000000750.
   PubMed Web of Science ®Google Scholar
• Dehkohneh, A., P. Jafari, and H. Fahimi. 2019. Effects of probiotic Lactobacillus paracasei TD3 on moderation of cholesterol biosynthesis pathway in rats. Iranian Journal of Basic Medical Sciences 22:1004–9. doi: 10.22038/ijbms.2019.33933.8073.
   PubMed Web of Science ®Google Scholar
• Eckel, R. H., J. M. Jakicic, J. D. Ard, J. M. de Jesus, N. H. Miller, V. S. Hubbard, I. M. Lee, A. H. Lichtenstein, C. M. Loria, B. E. Millen, et al. 2014. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 63 (25):2960–84. doi: 10.1016/j.jacc.2013.11.003.
   PubMed Web of Science ®Google Scholar
• Emoto, T., T. Yamashita, N. Sasaki, Y. Hirota, T. Hayashi, A. So, K. Kasahara, K. Yodoi, T. Matsumoto, T. Mizoguchi, et al. 2016. Analysis of gut microbiota in coronary artery disease patients: A possible link between gut microbiota and coronary artery disease. Journal of Atherosclerosis and Thrombosis 23 (8):908–21. doi: 10.5551/jat.32672.
   PubMed Web of Science ®Google Scholar
• Estruch, R., E. Ros, J. Salas-Salvado, M. I. Covas, D. Corella, F. Aros, E. Gomez-Gracia, V. Ruiz-Gutiérrez, M. Fiol, J. Lapetra, et al. 2018. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. The New England Journal of Medicine 378 (25):e34. doi: 10.1056/NEJMoa1800389.
   PubMed Web of Science ®Google Scholar
• Garcia-Mantrana, I., M. Selma-Royo, C. Alcantara, and M. C. Collado. 2018. Shifts on gut microbiota associated to Mediterranean diet adherence and specific dietary intakes on general adult population. Frontiers in Microbiology 9:890. doi: 10.3389/fmicb.2018.00890.
   PubMed Web of Science ®Google Scholar
• Gibson, G. R., H. M. Probert, J. V. Loo, R. A. Rastall, and M. B. Roberfroid. 2004. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutrition Research Reviews 17 (2):259–75. doi: 10.1079/NRR200479.
   PubMed Web of Science ®Google Scholar
• Gomez-Arango, L. F., H. L. Barrett, H. D. McIntyre, L. K. Callaway, M. Morrison, and M. Dekker Nitert. 2016. Increased systolic and diastolic blood pressure is associated with altered gut microbiota composition and butyrate production in early pregnancy. Hypertension 68 (4):974–81. doi: 10.1161/HYPERTENSIONAHA.116.07910.
   PubMed Web of Science ®Google Scholar
• Gregory, J. C., J. A. Buffa, E. Org, Z. Wang, B. S. Levison, W. Zhu, M. A. Wagner, B. J. Bennett, L. Li, J. A. DiDonato, et al. 2015. Transmission of atherosclerosis susceptibility with gut microbial transplantation. The Journal of Biological Chemistry 290 (9):5647–60. doi: 10.1074/jbc.M114.618249.
   PubMed Web of Science ®Google Scholar
• Guasch-Ferre, M., F. B. Hu, M. A. Martinez-Gonzalez, M. Fito, M. Bullo, R. Estruch, E. Ros, D. Corella, J. Recondo, E. Gómez-Gracia, et al. 2014. Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED study. BMC Medicine 12:78. doi: 10.1186/1741-7015-12-78.
   PubMed Web of Science ®Google Scholar
• Guasch-Ferre, M., F. B. Hu, M. Ruiz-Canela, M. Bullo, E. Toledo, D. D. Wang, D. Corella, E. Gómez-Gracia, M. Fiol, R. Estruch, et al. 2017. Plasma metabolites from choline pathway and risk of cardiovascular disease in the PREDIMED (Prevention With Mediterranean Diet) study. Journal of the American Heart Association 6 (11):e006524. doi: 10.1161/JAHA.117.006524.
   PubMed Web of Science ®Google Scholar
• Guo, X., A. Tresserra-Rimbau, R. Estruch, M. A. Martinez-Gonzalez, A. Medina-Remon, O. Castaner, D. Corella, J. Salas-Salvado, and R. M. Lamuela-Raventos. 2016. Effects of polyphenol, measured by a biomarker of total polyphenols in urine, on cardiovascular risk factors after a long-term follow-up in the PREDIMED study. Oxidative Medicine and Cellular Longevity 2016:2572606. doi: 10.1155/2016/2572606.
   PubMed Web of Science ®Google Scholar
• Haghikia, A., X. S. Li, T. G. Liman, N. Bledau, D. Schmidt, F. Zimmermann, N. Krankel, C. Widera, K. Sonnenschein, A. Haghikia, et al. 2018. Gut microbiota-dependent trimethylamine N-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes. Arteriosclerosis, Thrombosis, and Vascular Biology 38 (9):2225–35. doi: 10.1161/ATVBAHA.118.311023.
   PubMed Web of Science ®Google Scholar
• Hiro, T., T. Kimura, T. Morimoto, K. Miyauchi, Y. Nakagawa, M. Yamagishi, Y. Ozaki, K. Kimura, S. Saito, T. Yamaguchi, et al. 2009. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: A multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). Journal of the American College of Cardiology 54 (4):293–302. doi: 10.1016/j.jacc.2009.04.033.
   PubMed Web of Science ®Google Scholar
• Holscher, M. E., C. Bode, and H. Bugger. 2016. Diabetic cardiomyopathy: Does the type of diabetes matter? International Journal of Molecular Sciences 17 (12):2136. doi: 10.3390/ijms17122136.
   Web of Science ®Google Scholar
• Jie, Z., H. Xia, S. L. Zhong, Q. Feng, S. Li, S. Liang, H. Zhong, Z. Liu, Y. Gao, H. Zhao, et al. 2017. The gut microbiome in atherosclerotic cardiovascular disease. Nature Communications 8 (1):845. doi: 10.1038/s41467-017-00900-1.
   PubMed Web of Science ®Google Scholar
• Jumar, A., and R. E. Schmieder. 2016. Cocoa flavanol cardiovascular effects beyond blood pressure reduction. Journal of Clinical Hypertension (Greenwich, Conn.) 18 (4):352–8. doi: 10.1111/jch.12715.
   PubMed Web of Science ®Google Scholar
• Karlsson, F. H., F. Fak, I. Nookaew, V. Tremaroli, B. Fagerberg, D. Petranovic, F. Backhed, and J. Nielsen. 2012. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nature Communications 3:1245. doi: 10.1038/ncomms2266.
   PubMed Web of Science ®Google Scholar
• Khalesi, S., J. Sun, N. Buys, and R. Jayasinghe. 2014. Effect of Probiotics on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Hypertension 64 (4):897–903. doi: 10.1161/HYPERTENSIONAHA.114.03469.
   PubMed Web of Science ®Google Scholar
• Khan, T. J., Y. M. Ahmed, M. A. Zamzami, S. A. Mohamed, I. Khan, O. A. S. Baothman, M. G. Mehanna, and M. Yasir. 2018. Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats. Scientific Reports 8 (1):662. doi: 10.1038/s41598-017-19013-2.
   PubMedGoogle Scholar
• Kim, J., H. Lee, J. An, Y. Song, C. K. Lee, K. Kim, and H. Kong. 2019. Alterations in gut microbiota by statin therapy and possible intermediate effects on hyperglycemia and hyperlipidemia. Frontiers in Microbiology 10:1947. doi: 10.3389/fmicb.2019.01947.
   PubMed Web of Science ®Google Scholar
• Knuuti, J., W. Wijns, A. Saraste, D. Capodanno, E. Barbato, C. Funck-Brentano, E. Prescott, R. F. Storey, C. Deaton, T. Cuisset, et al. 2020. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal 41 (3):407–77. doi: 10.1093/eurheartj/ehz425.
   PubMed Web of Science ®Google Scholar
• Ko, Y. G., J. H. Jung, S. Park, E. Choi, B. Joung, K. C. Hwang, J. W. Ha, D. Choi, Y. Jang, N. Chung, et al. 2006. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction. International Journal of Cardiology 112 (1):66–71. doi: 10.1016/j.ijcard.2005.10.005.
   PubMed Web of Science ®Google Scholar
• Koeth, R. A., Z. Wang, B. S. Levison, J. A. Buffa, E. Org, B. T. Sheehy, E. B. Britt, X. Fu, Y. Wu, L. Li, et al. 2013. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature Medicine 19 (5):576–85. doi: 10.1038/nm.3145.
   PubMed Web of Science ®Google Scholar
• Koh, A., F. De Vadder, P. Kovatcheva-Datchary, and F. Backhed. 2016. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165 (6):1332–45. doi: 10.1016/j.cell.2016.05.041.
   PubMed Web of Science ®Google Scholar
• Larroya-Garcia, A., D. Navas-Carrillo, and E. Orenes-Piñero. 2019. Impact of gut microbiota on neurological diseases: Diet composition and novel treatments. Critical Reviews in Food Science and Nutrition 59 (19):3102–16. doi: 10.1080/10408398.2018.1484340.
   PubMed Web of Science ®Google Scholar
• Li, J., F. Zhao, Y. Wang, J. Chen, J. Tao, G. Tian, S. Wu, W. Liu, Q. Cui, B. Geng, et al. 2017. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5 (1):14. doi: 10.1186/s40168-016-0222-x.
   PubMed Web of Science ®Google Scholar
• Liu, H., X. Chen, X. Hu, H. Niu, R. Tian, H. Wang, H. Pang, L. Jiang, B. Qiu, X. Chen, et al. 2019. Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome 7 (1):68. doi: 10.1186/s40168-019-0683-9.
   PubMed Web of Science ®Google Scholar
• Liu, X., Z. Xie, M. Sun, X. Wang, J. Li, J. Cui, F. Zhang, L. Yin, D. Huang, J. Hou, et al. 2018. Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomography. International Journal of Cardiology 265:18–23. doi: 10.1016/j.ijcard.2018.04.126.
   PubMed Web of Science ®Google Scholar
• Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. 1998. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The New England Journal of Medicine 339:1349–57. doi: 10.1056/NEJM199811053391902.
   PubMed Web of Science ®Google Scholar
• Makki, N., T. M. Brennan, and S. Girotra. 2015. Acute coronary syndrome. Journal of Intensive Care Medicine 30 (4):186–200. doi: 10.1177/0885066613503294.
   PubMed Web of Science ®Google Scholar
• Marchesi, J. R., D. H. Adams, F. Fava, G. D. Hermes, G. M. Hirschfield, G. Hold, M. N. Quraishi, J. Kinross, H. Smidt, K. M. Tuohy, et al. 2016. The gut microbiota and host health: A new clinical frontier. Gut 65 (2):330–9. doi: 10.1136/gutjnl-2015-309990.
   PubMed Web of Science ®Google Scholar
• Mozaffarian, D., E. J. Benjamin, A. S. Go, D. K. Arnett, M. J. Blaha, M. Cushman, S. R. Das, S. de Ferranti, J. P. Després, H. J. Fullerton, et al. 2016. Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation 133 (4):e38–360. doi: 10.1161/CIR.0000000000000350.
   PubMed Web of Science ®Google Scholar
• Naruszewicz, M., M. L. Johansson, D. Zapolska-Downar, and H. Bukowska. 2002. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. The American Journal of Clinical Nutrition 76 (6):1249–55. doi: 10.1093/ajcn/76.6.1249.
   PubMed Web of Science ®Google Scholar
• Navas-Carrillo, D., F. Marin, M. Valdes, and E. Orenes-Pinero. 2017. Deciphering acute coronary syndrome biomarkers: High-resolution proteomics in platelets, thrombi and microparticles. Critical Reviews in Clinical Laboratory Sciences 54 (1):49–58. doi: 10.1080/10408363.2016.1241214.
   PubMed Web of Science ®Google Scholar
• Oesterle, A., U. Laufs, and J. K. Liao. 2017. Pleiotropic effects of statins on the cardiovascular system. Circulation Research 120 (1):229–43. doi: 10.1161/CIRCRESAHA.116.308537.
   PubMed Web of Science ®Google Scholar
• Orenes-Piñero, E., D. Hernandez-Romero, E. Jover, G. de la Morena, M. Valdes, and F. Marin. 2011. An insight of novel pharmacological therapies in hypertrophic cardiomyopathy. Medicinal Chemistry (Shariqah (United Arab Emirates)) 7 (4):275–85. doi: 10.2174/157340611796150941.
   PubMed Web of Science ®Google Scholar
• Pang, J., Z. Zhang, T. Z. Zheng, B. A. Bassig, C. Mao, X. Liu, Y. Zhu, K. Shi, J. Ge, Y. J. Yang, et al. 2016. Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis. International Journal of Cardiology 202:967–74. doi: 10.1016/j.ijcard.2014.12.176.
   PubMed Web of Science ®Google Scholar
• Peng, J., X. Xiao, M. Hu, and X. Zhang. 2018. Interaction between gut microbiome and cardiovascular disease. Life Sciences 214:153–7. doi: 10.1016/j.lfs.2018.10.063.
   PubMed Web of Science ®Google Scholar
• Pluznick, J. 2014. A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes 5 (2):202–7. doi: 10.4161/gmic.27492.
   PubMed Web of Science ®Google Scholar
• Ramirez-Farias, C., K. Slezak, Z. Fuller, A. Duncan, G. Holtrop, and P. Louis. 2008. Effect of inulin on the human gut microbiota: Stimulation of bifidobacterium adolescentis and Faecalibacterium prausnitzii. British Journal of Nutrition 101 (4):541–50. doi: 10.1017/S0007114508019880.
   PubMed Web of Science ®Google Scholar
• Randrianarisoa, E., A. Lehn-Stefan, X. Wang, M. Hoene, A. Peter, S. S. Heinzmann, X. Zhao, I. Königsrainer, A. Königsrainer, B. Balletshofer, et al. 2016. Relationship of serum trimethylamine N-oxide (TMAO) levels with early atherosclerosis in humans. Scientific Reports 6 (1):26745. doi: 10.1038/srep26745.
   PubMedGoogle Scholar
• Rerksuppaphol, S., and L. Rerksuppaphol. 2015. A randomized double-blind controlled trial of Lactobacillus acidophilus plus bifidobacterium bifidum versus placebo in patients with hypercholesterolemia. Journal of Clinical and Diagnostic Research 9:KC01-4. doi: 10.7860/JCDR/2015/11867.5728.
   PubMedGoogle Scholar
• Roncal, C., E. Martinez-Aguilar, J. Orbe, S. Ravassa, A. Fernandez-Montero, G. Saenz-Pipaon, A. Ugarte, A. Estella-Hermoso de Mendoza, J. A. Rodriguez, S. Fernández-Alonso, et al. 2019. Trimethylamine-N-oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease. Scientific Reports 9 (1):15580. doi: 10.1038/s41598-019-52082-z.
   PubMedGoogle Scholar
• Ros, E., M. A. Martinez-Gonzalez, R. Estruch, J. Salas-Salvado, M. Fito, J. A. Martinez, and D. Corella. 2014. Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study. Advances in Nutrition (Bethesda, Md.) 5 (3):330S–6S. doi: 10.3945/an.113.005389.
   PubMed Web of Science ®Google Scholar
• Saikia, D., A. K. Manhar, B. Deka, R. Roy, K. Gupta, N. D. Namsa, P. Chattopadhyay, R. Doley, and M. Mandal. 2018. Hypocholesterolemic activity of indigenous probiotic isolate saccharomyces cerevisiae ARDMC1 in a rat model. Journal of Food and Drug Analysis 26 (1):154–62. doi: 10.1016/j.jfda.2016.12.017.
   PubMed Web of Science ®Google Scholar
• Sanchez-Alcoholado, L., D. Castellano-Castillo, L. Jordan-Martinez, I. Moreno-Indias, P. Cardila-Cruz, D. Elena, A. J. Munoz-Garcia, M. I. Queipo-Ortuno, and M. Jimenez-Navarro. 2017. Role of gut microbiota on cardio-metabolic parameters and immunity in coronary artery disease patients with and without type-2 diabetes mellitus. Frontiers in Microbiology 8:1936. doi: 10.3389/fmicb.2017.01936.
   PubMed Web of Science ®Google Scholar
• Sanders, M. E. 2008. Probiotics: Definition, sources, selection, and uses. Clinical Infectious Diseases46 (Suppl 2):S58–S61; discussion S144–51. doi: 10.1086/523341.
   PubMed Web of Science ®Google Scholar
• Sender, R., S. Fuchs, and R. Milo. 2016. Revised estimates for the number of human and bacteria cells in the body. PLoS Biology 14 (8):e1002533. doi: 10.1371/journal.pbio.1002533.
   PubMed Web of Science ®Google Scholar
• Senthong, V., Z. Wang, Y. Fan, Y. Wu, S. L. Hazen, and W. H. W. Tang. 2016. Trimethylamine N-oxide and mortality risk in patients with peripheral artery disease. Journal of the American Heart Association 5 (10):e004237. doi: 10.1161/JAHA.116.004237.
   PubMed Web of Science ®Google Scholar
• Senthong, V., Z. Wang, X. S. Li, Y. Fan, Y. Wu, W. H. W. Tang, and S. L. Hazen. 2016. Intestinal microbiota-generated metabolite trimethylamine-N-oxide and 5-year mortality risk in stable coronary artery disease: The contributory role of intestinal microbiota in a COURAGE-like patient cohort. Journal of the American Heart Association 5 (6):e002816. doi: 10.1161/JAHA.115.002816.
   PubMed Web of Science ®Google Scholar
• Sever, P. S., B. Dahlof, N. R. Poulter, H. Wedel, G. Beevers, M. Caulfield, R. Collins, S. E. Kjeldsen, A. Kristinsson, G. T. McInnes, et al. 2003. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the anglo-scandinavian cardiac outcomes trial–lipid lowering arm (ASCOT-LLA): A multicentre randomis. Lancet 361 (9364):1149–58. doi: 10.1016/S0140-6736(03)12948-0.
   PubMed Web of Science ®Google Scholar
• Sigvant, B., P. Hasvold, M. Thuresson, T. Jernberg, M. Janzon, and J. Nordanstig. 2019. Myocardial infarction and peripheral arterial disease: Treatment patterns and long-term outcome in men and women results from a Swedish nationwide study. European Journal of Preventive Cardiology. doi: 10.1177/2047487319893046.
   PubMedGoogle Scholar
• Smits, L. P., R. S. Kootte, E. Levin, A. Prodan, S. Fuentes, E. G. Zoetendal, Z. Wang, B. S. Levison, M. C. P. Cleophas, E. M. Kemper, et al. 2018. Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome. Journal of the American Heart Association 7 (7):e008342. doi: 10.1161/JAHA.117.008342.
   PubMed Web of Science ®Google Scholar
• Sonnenburg, J. L., and F. Backhed. 2016. Diet-microbiota interactions as moderators of human metabolism. Nature 535 (7610):56–64. doi: 10.1038/nature18846.
   PubMed Web of Science ®Google Scholar
• Sun, B., L. Li, and X. Zhou. 2018. Comparative analysis of the gut microbiota in distinct statin response patients in East China. Journal of Microbiology (Seoul, Korea) 56 (12):886–92. doi: 10.1007/s12275-018-8152-x.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., L. M. Heaney, D. J. L. Jones, and L. L. Ng. 2017. Trimethylamine N-oxide and risk stratification after acute myocardial infarction. Clinical Chemistry 63 (1):420–8. doi: 10.1373/clinchem.2016.264853.
   PubMed Web of Science ®Google Scholar
• Tang, W. H. W., T. Kitai, and S. L. Hazen. 2017. Gut microbiota in cardiovascular health and disease. Circulation Research 120 (7):1183–96. doi: 10.1161/CIRCRESAHA.117.309715.
   PubMed Web of Science ®Google Scholar
• Tang, W. H. W., Z. Wang, B. S. Levison, R. A. Koeth, E. B. Britt, X. Fu, Y. Wu, and S. L. Hazen. 2013. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. New England Journal of Medicine 368 (17):1575–84. doi: 10.1056/NEJMoa1109400.
   PubMed Web of Science ®Google Scholar
• Vindigni, S. M., and C. M. Surawicz. 2017. Fecal microbiota transplantation. Gastroenterology Clinics of North America 46 (1):171–85. doi: 10.1016/j.gtc.2016.09.012.
   PubMed Web of Science ®Google Scholar
• Wang, L., M. J. Guo, Q. Gao, J. F. Yang, L. Yang, X. L. Pang, and X. J. Jiang. 2018. The effects of probiotics on total cholesterol: A meta-analysis of randomized controlled trials. Medicine 97 (5):e9679. doi: 10.1097/MD.0000000000009679.
   PubMed Web of Science ®Google Scholar
• Wang, L., Y. Wang, H. Wang, X. Zhou, X. Wei, Z. Xie, Z. Zhang, K. Wang, and J. Mu. 2018. The influence of the intestinal microflora to the efficacy of rosuvastatin. Lipids in Health and Disease 17 (1):151. doi: 10.1186/s12944-018-0801-x.
   PubMedGoogle Scholar
• Wu, G. D., J. Chen, C. Hoffmann, K. Bittinger, Y. Y. Chen, S. A. Keilbaugh, M. Bewtra, D. Knights, W. A. Walters, R. Knight, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science (New York, N.Y.) 334 (6052):105–8. doi: 10.1126/science.1208344.
   PubMed Web of Science ®Google Scholar
• Wu, Y., Q. Zhang, Y. Ren, and Z. Ruan. 2017. Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials. PloS One 12 (6):e0178868. doi: 10.1371/journal.pone.0178868.
   PubMed Web of Science ®Google Scholar
• Wu, Z. X., S. F. Li, H. Chen, J. X. Song, Y. F. Gao, F. Zhang, and C. F. Cao. 2017. The changes of gut microbiota after acute myocardial infarction in rats. PLoS One 12 (7):e0180717. doi: 10.1371/journal.pone.0180717.
   PubMed Web of Science ®Google Scholar
• Yamashita, T., T. Emoto, N. Sasaki, and K. I. Hirata. 2016. Gut microbiota and coronary artery disease. International Heart Journal 57 (6):663–71. doi: 10.1536/ihj.16-414.
   PubMed Web of Science ®Google Scholar
• Yang, T., M. M. Santisteban, V. Rodriguez, E. Li, N. Ahmari, J. M. Carvajal, M. Zadeh, M. Gong, Y. Qi, J. Zubcevic, et al. 2015. Gut dysbiosis is linked to hypertension. Hypertension (Dallas, Tex.: 1979) 65 (6):1331–40. doi: 10.1161/HYPERTENSIONAHA.115.05315.
   PubMed Web of Science ®Google Scholar
• Yoo, J. Y., and S. S. Kim. 2016. Probiotics and prebiotics: Present status and future perspectives on metabolic disorders. Nutrients 8 (3):173. doi: 10.3390/nu8030173.
   PubMed Web of Science ®Google Scholar
• Yoshida, N., T. Emoto, T. Yamashita, H. Watanabe, T. Hayashi, T. Tabata, N. Hoshi, N. Hatano, G. Ozawa, N. Sasaki, et al. 2018. Bacteroides vulgatus and bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation 138 (22):2486–98. doi: 10.1161/CIRCULATIONAHA.118.033714.
   PubMed Web of Science ®Google Scholar
• Yoshida, N., T. Yamashita, and K. Hirata. 2018. Gut microbiome and cardiovascular diseases. Diseases 6 (3):56. doi: 10.3390/diseases6030056.
   Google Scholar
• Zatorski, H., and J. Fichna. 2014. What is the future of the gut microbiota-related treatment? Toward modulation of microbiota in preventive and therapeutic medicine. Frontiers in Medicine 1:19. doi: 10.3389/fmed.2014.00019.
   Google Scholar
• Zhu, Y., Q. Li, and H. Jiang. 2020. Gut microbiota in atherosclerosis: Focus on trimethylamine N-oxide. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 128 (5):353–66. doi: 10.1111/apm.13038.
   PubMed Web of Science ®Google Scholar
• WHO. 2020a. Cardiovascular disease. https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed October 20, 2020.
   Google Scholar
• WHO. 2020b. Cardiovascular disease. https://www.who.int/cardiovascular_diseases/about_cvd/en/. Accessed October 20, 2020.
   Google Scholar